Temsirolimus Kit
Product Images NDC 68083-202

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Temsirolimus (NDC 68083-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Temsirolimus-spl-structure (Temsirolimus Spl Structure)

Chemical structure diagram of Temsirolimus, showing its molecular composition and arrangement typically used to represent the active ingredient in the Temsirolimus Injection kit by Gland Pharma Limited.*

FDA Label Image

Temsirolimus-spl-graph1 (Temsirolimus Spl Graph1)

A survival distribution function graph comparing interferon and Temsirolimus injection, 25 mg. The x-axis represents months to death from randomization, and the y-axis shows the survival distribution function. The solid line represents Temsirolimus injection, and the dashed line represents interferon.*

FDA Label Image

Temsirolimus-spl-product-label1 (Temsirolimus Spl Product Label1)

Label for Temsirolimus Injection 25 mg/mL per vial, a sterile human prescription drug. The label specifies intravenous infusion use only, single dose vial, and refrigeration storage. It notes dilution instructions with specified diluents and contains 49.90% v/v dehydrated alcohol. The label also includes an NDC number, barcode, and batch information area.*

FDA Label Image

Temsirolimus-spl-diluent-label1 (Temsirolimus Spl Diluent Label1)

Label for Diluent for Temsirolimus Injection 2.2 mL, a sterile product for dilution only, not for direct administration. It is a single dose vial labeled to refrigerate and contains dehyrated alcohol 25.14% v/v. The label includes usage instructions referencing the insert and a barcode with product details from Gland Pharma Limited.*

FDA Label Image

Temsirolimus-spl-carton-label (Temsirolimus Spl Carton Label)

Packaging label for Temsirolimus Injection 25 mg/mL per vial, a kit for intravenous infusion. The label indicates each single dose vial contains 0.2 mL overfill, requires dilution before administration to 10 mg/mL, and includes a vial of Temsirolimus Injection along with a diluent. Manufactured by Gland Pharma Limited. Refrigeration is required.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.